Inhibikase Therapeutics (IQT0.STU) Q2 2026 Earnings

12MayConfirmed
Q1 2026
Q2 2026
-0.09
-0.09
-0.09
-0.09

Details

Expected EPS
-0.09229863267
Actual EPS
-0.08519900000000001
Surprise EPS
0.01
Surprise Percent
+7.69%

Description

Inhibikase Therapeutics (IQT0.STU) has reported earnings of -0.08519900000000001 per share for Q2 2026.

0 Comments

Share your thoughts